SequelSEC

Apyx Medical Corp APYX

Surgical & Medical Instruments & Apparatus · CIK 0000719135 · Fiscal year ends 1231

Revenue
$58.42M
Fiscal year ended 2026-06-30
Operating income
-$3.54M
Fiscal year ended 2026-06-30
Free cash flow
-$11.05M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$79.80MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.91Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue1.5×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity5.4×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Long-term debt / equity2.35x87th
Current ratio5.00x74th
R&D / revenue6.4%28th
SBC / revenue3.8%39th
Revenue YoY growth9.9%39th
CapEx / revenue2.1%44th
Operating margin-12.2%55th
FCF margin-17.2%46th
Gross margin62.5%53th
Net margin-21.2%52th

Apyx Medical Corp (APYX) reported revenue of $58.42M and net income of -$8.63M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Apyx Medical Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Apyx Medical Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$58.42M
Cost of revenue$21.32M
Gross profit$37.09M
Operating income-$3.54M
Net income-$8.63M
Research & development$3.30M
Weighted-average diluted sharesUnavailable
Pretax income-$7.97M
Income tax expense$439.00K
Diluted EPSUnavailable
Selling, general & administrative$17.14M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Apyx Medical Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$27.62M
Total assets$61.07M
Current assets$53.16M
Total liabilities$49.98M
Current liabilities$9.35M
Total equity incl. NCI$11.09M
Temporary (mezzanine) equityUnavailable
Inventory$10.75M
Accounts receivable$13.61M
GoodwillUnavailable
Long-term debt$35.33M
Accounts payable$2.19M

Cash flow

Apyx Medical Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$10.13M
Capital expenditures$920.00K
Investing cash flow-$920.00K
Financing cash flow$9.61M
Net change in cash-$1.68M
Stock-based compensation$2.42M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$783.00K

Derived

Apyx Medical Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$11.05M
Gross margin63.5%
Operating margin-6.1%
FCF margin-18.9%
SBC / revenue4.1%
Current ratio5.68x
Revenue YoY growth25.6%
Net margin-14.8%
R&D / revenue5.7%
CapEx / revenue1.6%
Long-term debt / equity3.19x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open APYX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-10View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.